首頁 > 市場調查報告書 > 醫療設備

醫學影像診斷內視鏡檢查設備

市場調查報告書

商品編碼

1735633

2026 年至 2032 年大腸鏡檢查設備市場（按產品類型、最終用戶、應用和地區）

Colonoscopy Devices Market By Product Type, By End- User, By Application, And Region for 2026-2032.

出版日期: 2025年05月02日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

大腸鏡檢查設備市場評估（2026-2032）

隨著全球大腸直腸癌發生率的上升和大腸鏡檢查數量的增加，大腸鏡設備市場正在快速擴張。由於對創新、技術先進的器械和大腸鏡設備的需求旺盛，預計市場規模還將擴大。根據 Verified Market Research 分析師預測，大腸鏡設備市場規模將從 2024 年的約 15.9 億美元下降到 2032 年預測期間的 22.5 億美元。

大腸直腸癌發病率的上升和預防性篩檢計畫的日益普及正在推動大腸鏡檢查設備市場的發展，預計從 2026 年到 2032 年，大腸鏡檢查設備市場將以 5% 的複合年成長率成長。

人口老化如何推動大腸鏡檢查設備市場？

全球人口老化和慢性病盛行率上升推動了大腸鏡檢查設備市場的發展。根據世界衛生組織 (WHO) 的數據，到 2020 年，全球將有近 14 億人年齡在 60 歲或以上。成年人罹患大腸癌的風險正在上升，這刺激了對大腸鏡檢查設備的需求。根據美國國家癌症中心的數據，全球每 10 萬名男性和女性中，有 36.6% 患有大腸癌。每年每 10 萬名男性和女性的死亡率為 13.1%。

美國國家醫學圖書館預測，到2040年，大腸癌病例數將達到320萬，導致大腸鏡檢查的頻率更高。

此外，透過教育計畫和公共衛生宣傳活動，大腸直腸癌相關知識的提升，也有效地凸顯了大腸直腸癌以及大腸鏡檢查作為預防性篩檢手段的價值。隨著公眾意識的增強，越來越多的人選擇接受大腸鏡檢查，從而推動了市場的成長。

感染風險將如何抑制大腸鏡檢查設備市場的成長？

儘管設備設計和消毒措施不斷進步，但結腸鏡檢查過程中仍存在交叉污染和感染傳播的風險。根據美國國家醫學圖書館的數據，大腸直腸癌是第二大常見癌症。近期篩檢中，已有超過30萬人被診斷出罹患大腸癌。徹底清洗和消毒可重複使用的內視鏡設備至關重要，但這也帶來了物流和成本方面的挑戰。一次性設備已被提案作為解決此問題的方案，但它會顯著增加治療成本，同時也引發了對醫療廢棄物和環境的擔憂。

此外，大腸鏡檢查的廣泛普及也因設備和操作本身的高昂成本而受到阻礙。開發先進的大腸鏡檢查設備需要大量的研發、監管支出和複雜的製造流程。這些成本最終轉嫁給醫療服務提供者，並最終轉嫁給患者。在缺乏全面醫療保險體系或經濟成長緩慢的國家，這些高昂的成本嚴重限制了人們獲得這項可能挽救生命的檢查的機會。

The market for colonoscopy devices is quickly rising as colorectal cancer rates rise and the number of colonoscopy procedures conducted worldwide increases. Also, the market is expected to grow because of the high demand for innovative, technologically sophisticated gadgets and colonoscopy equipment. According to the analyst from Verified Market Research, the Colonoscopy Devices Market is estimated to reach a valuation of USD 2.25 Billion over the forecast period 2032, subjugating around USD 1.59 Billion valued in 2024.

The rising frequency of colorectal cancer, as well as the expanding acceptance of preventative screening programs, are driving the Colonoscopy Devices Market. It enables the market to grow at a CAGR of 5% from 2026-2032.

How is the Geriatric Population Driving the Colonoscopy Devices Market?

The increasing aging population globally, and the increasing prevalence of chronic disorders over the globe are driving the Colonoscopy Devices Market. According to the World Health Organization (WHO) in 2020 almost 1.4 billion people were above 60 years aged. The risk of colorectal cancer is increasing in adults, which is fueling the demand for colonoscopy devices. According to the National Cancer Institute, globally 36.6% of people per 100,000 men and women were detected by colorectal cancer. The death rate was 13.1% per 100,000 men and women per year.

The increasing number of colorectal cancer is predicted by the National Library of Medicine by 2040 will be 3.2 million and the disease is leading to more frequent colonoscopy procedures.

Furthermore, increasing knowledge about colorectal cancer educational programs and public health campaigns are doing a good job of bringing colorectal cancer and the value of colonoscopies as a preventive screening to light. As a result of this greater awareness, more people are choosing to have colonoscopies, which propels market expansion.

How Does Risk of Infection Constrain the Growth of the Colonoscopy Devices Market?

Despite advances in gadget design and sterilizing measures, there is still a danger of cross-contamination and infection transmission during colonoscopy procedures. According to the National Library of Medicine, colorectal cancer is the second cancer. Recent examinations show that more than 300,000 people were detected with colorectal cancer. The thorough cleaning and sanitation of reusable endoscopic equipment is vital, but it poses logistical and cost issues. Single-use devices have been offered as a solution to this problem, however, they significantly enhance the cost of treatments while also raising concerns about medical waste and the environment.

Furthermore, the high expense of both the gadgets and the procedures themselves is a significant impediment to the widespread use of colonoscopy. The development of sophisticated colonoscopy gadgets necessitates extensive R&D, regulatory compliance expenditures, and manufacturing complexity. These costs are passed on to healthcare providers and, eventually, patients. In nations with less comprehensive health insurance coverage or lesser economic growth, these expenses severely limit access to potentially life-saving surgeries.

Category-Wise Acumens

Will Visualization Systems Outplace Colonoscopy Device Market?

The visualization system is estimated to exhibit the highest growth within the market during the forecast period. The visualization system is used to screen for cancer in the small intestine, rectum, and anus. A minimally intrusive diagnostic for assessing the possibility of internal organ cancer is a virtual colonoscopy.

Screening (CT) colonography is another name for virtual colonoscopy. It is used for radiologist X-rays. It finds the diseases at an early stage. According to the National Institute of Diabetes and Digestive and Kidney Diseases, doctors recommend CT screening for colonoscopy and rectal cancer at the age of 45 if there is no health issue.

Furthermore, colonoscopy usage is expected to increase as long as technology continues to evolve, leading to better mobility and disposable choices. Visualization systems currently don't outplace colonoscopy devices.

How the increasing prevalence of Colorectal Cancer in adults is driving the Colorectal Cancer segment?

The colorectal cancer segment is estimated to dominate the market during the forecast period. In the U.S. around 18,000 people under the age of 50 are getting diagnosed with colorectal cancer. According to the National Cancer Institute, the risk of colorectal cancer is increasing in older adults because of smoking, physical inactivity, and obesity.

Risk fare increasing in adults under the age of 45, 10% to 20% of early-onset colorectal cancer is caused because of inherited factors. Due to an unhealthy diet, and low intake of fruits and vegetables the early stage the cancer is caused.

Furthermore, the growth incidence and its impact on the demand for colonoscopy devices can be attributed to several factors such as lifestyle, rising healthcare expenditure, increasing awareness, and screening efforts. The combination of demographic trends and infrastructure improvements contributes to the growing incidence of colorectal cancer and, consequently, the increasing demand for colonoscopy devices.

Country/Region-wise Acumens

How does the Developed Healthcare System Drive the North American Colonoscopy Devices Market?

North America region is estimated to dominate the market during the forecast period due to the improving prevalence of rectal diseases, the existence of a developed healthcare system, the growing emphasis on the development of innovative products, and the increasing number of companies manufacturing colonoscopy devices. The governments are running several health campaigns to raise awareness of colon problems among the local populace.

North America, particularly the United States, has one of the most advanced healthcare systems in the world. This comprises cutting-edge medical facilities, advanced medical technologies, and highly skilled healthcare staff. Also, healthcare spending in the region is far higher than in other parts of the world. This financial commitment promotes the use of modern medical technology, particularly colonoscopy machines, which aid in the early identification and treatment of gastrointestinal disorders such as colorectal cancer.

Furthermore, Colorectal cancer is common in North America and is the biggest cause of cancer-related fatalities in the region. The American Cancer Society emphasizes the significance of regular screening for early identification of colorectal cancer, which drives up demand for colonoscopy instruments. Also, the increasing prevalence of other gastrointestinal disorders as a result of food habits, lifestyle changes, and an older population drives up demand for these devices.

What Factors Contribute to the Growth of the Asia Pacific Region in the Market?

The Asia Pacific region is estimated to exhibit the highest growth during the forecast period. Countries in the Asia Pacific region, including China, India, and Japan, are experiencing significant increases in healthcare spending, both at the government and individual levels. This increased spending is being directed toward modernizing healthcare infrastructure, such as hospitals and diagnostic facilities outfitted with cutting-edge medical technology. As healthcare accessibility grows, so does the adoption of advanced diagnostic instruments, such as colonoscopy devices, to meet an increasing demand for high-quality healthcare services.

Furthermore, the Asia Pacific region is experiencing a rapid increase in the prevalence of colorectal cancer and other gastrointestinal disorders, which can be ascribed to changing lifestyles, dietary habits, and aging populations. These factors have raised awareness about the need for early detection and prevention, increasing demand for colonoscopy treatments. Countries such as Japan have adopted screening programs that encourage regular colonoscopies, setting an example for other nations in the region.

Competitive Landscape

The competitive landscape of the colonoscopy device market is characterized by several key players and factors that influence market dynamics, innovation, and strategic initiatives. These players compete based on product offerings, technological advancements, market presence, pricing strategies, distribution networks, and partnerships.

Some of the prominent players operating in the Colonoscopy Devices Market include:

Boston Scientific, PENTAX Medical, Fujifilm Holdings, HOYA Group, Avantis Medical System, KARL STORZ, Medtronic, OLYMPUS, ANA-MED, Endomed Systems, Getinge Group, GI-View, HUGER Medical Instrument

Latest Developments

In March 2022, the FDA approved Wision A.I.'s colonoscopy technology for polyp detection. This approval will enhance patient outcomes and contribute to a decrease in colorectal cancer incidences.

In April 2022, Olympus 510(k) cleared the PCF colonoscope series, and SMART Medical Systems Ltd., a producer of cutting-edge endoscopic equipment, announced an additional Food and Drug Administration clearance for their G-EYE Colonoscope.

Colonoscopy Devices Market By Category

Product Type:

Visualization system

Colonoscope

Other instruments

End-use:

Hospitals

Clinics

Ambulatory Surgery Centers

Diagnostic Centers

Other

Application:

Colorectal Cancer

Lynch Syndrome

Ulcerative Colitis

Crohn's Disease

Polyps or Colorectal Cancer

Other Applications

Region:

North America

Europe

Asia-Pacific

South America

Middle East & Africa

1. INTRODUCTION OF GLOBAL COLONOSCOPY DEVICES MARKET

1.1. Overview of the Market
1.2. Scope of Report
1.3. Assumptions

2. EXECUTIVE SUMMARY

3. RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

3.1. Data Mining
3.2. Validation
3.3. Primary Interviews
3.4. List of Data Sources

4. GLOBAL COLONOSCOPY DEVICES MARKET OUTLOOK

4.1. Overview
4.2. Market Dynamics
- 4.2.1. Drivers
- 4.2.2. Restraints
- 4.2.3. Opportunities
4.3. Porters Five Force Model
4.4. Value Chain Analysis

5. GLOBAL COLONOSCOPY DEVICES MARKET, BY PRODUCT TYPE

5.1 Overview
5.2 Visualization system
5.3 Colonoscope
5.4 Other instruments

6. GLOBAL COLONOSCOPY DEVICES MARKET, BY END-USE

6.1. Overview
6.2 Hospitals
6.3 Clinics
6.4 Ambulatory Surgery Centers
6.5 Diagnostic Centers
6.6 Other

7. GLOBAL COLONOSCOPY DEVICES MARKET, BY APPLICATION

7.1. Overview
7.2 Colorectal Cancer
7.3 Lynch Syndrome
7.4 Ulcerative Colitis
7.5 Crohn's Disease
7.6 Polyps or Colorectal Cancer
7.7 Other Applications

8. GLOBAL COLONOSCOPY DEVICES MARKET, BY GEOGRAPHY

8.1. Overview
8.2. North America
- 8.2.1. U.S.
- 8.2.2. Canada
- 8.2.3. Mexico
8.3. Europe
- 8.3.1. Germany
- 8.3.2. U.K.
- 8.3.3. France
- 8.3.4. Rest of Europe
8.4. Asia Pacific
- 8.4.1. China
- 8.4.2. Japan
- 8.4.3. India
- 8.4.4. Rest of Asia Pacific
8.5. Rest of the World
- 8.5.1. Latin America
- 8.5.2. Middle East & Africa

9. GLOBAL COLONOSCOPY DEVICES MARKET COMPETITIVE LANDSCAPE

9.1. Overview
9.2. Company Market Ranking
9.3. Key Development Strategies

10. COMPANY PROFILES

10.1. Boston Scientific
- 10.1.1. Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Outlook
- 10.1.4. Key Developments
10.2. Fujifilm Holdings
- 10.2.1. Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Outlook
- 10.2.4. Key Developments
10.3. HOYA Group
- 10.3.1. Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Outlook
- 10.3.4. Key Developments
10.4. KARL STORZ
- 10.4.1. Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Outlook
- 10.4.4. Key Developments
10.5. OLYMPUS
- 10.5.1. Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Outlook
- 10.5.4. Key Developments
10.6. ANA-MED
- 10.6.1. Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Outlook
- 10.6.4. Key Developments
10.7. Avantis Medical Systems
- 10.7.1. Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Outlook
- 10.7.4. Key Developments
10.8. Endomed Systems
- 10.8.1. Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Outlook
- 10.8.4. Key Developments
10.9. Getinge Group
- 10.9.1. Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Outlook
- 10.9.4. Key Developments
10.10. HUGER Medical Instrument
- 10.10.1. Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Outlook
- 10.10.4. Key Developments